Atara Biotherapeutics Expands T-Cell Immunotherapy Collaboration to Advance Next-Generation CAR T Technologies … – Nasdaq
|
Atara Biotherapeutics Expands T–Cell Immunotherapy Collaboration to Advance Next-Generation CAR T Technologies …
Nasdaq SOUTH SAN FRANCISCO, Calif., May 08, 2018 (GLOBE NEWSWIRE) — Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T–cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral … |
